---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-026415"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2026-05-29T21:00:24+00:00"
generated_at: "2026-05-29T21:02:28.145493+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "medium"
source: SEC EDGAR
---

# Calidi Biotherapeutics issues amended warrant for 17.4M shares at $0.23, subject to stockholder approval

## Summary
- Issued amended warrant to accredited investor for 17,391,304 unvested shares at $0.23 exercise price.
- Exercise conditioned on stockholder approval; minimum vesting acquisition amount increased to $1M from $500K.
- Vesting termination date extended from July 8, 2026 to September 30, 2026.
- Private placement exempt under Section 4(a)(2) and Rule 506(b); shares not registered.

## SEC filing metadata
- accession: 0001493152-26-026415
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2026-05-29T21:00:24+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: medium
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315226026415/0001493152-26-026415-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315226026415/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-026415
- JSON: https://secwatch.observer/filing/0001493152-26-026415.json
- Plain text: https://secwatch.observer/filing/0001493152-26-026415.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.